Page 28 - GTM-3-3
P. 28

Global Translational Medicine                                  Computational advances in cancer liquid biopsy



            4. Repetitive elements (REs)                       remains a challenge, particularly in complex, repetitive
                                                               genomic regions. From a computational point of view, the
            An intriguing perspective in the field of cfDNA    hurdle of precisely assessing somatic TE activity lies in the
            epigenomics is represented by transposable elements (TEs),   difficulty of determining the exact genomic insertion sites
            which are major components of eukaryotic genomes. TEs   of elements that share very similar sequences, are repeated
            are known for their ability to mobilize to new genomic   in hundreds of thousands of genomic locations, and are
            locations, affecting gene expression regulation and   often embedded within one another.
            inducing the formation of double-strand breaks, genomic
            rearrangements, and epigenetic modifications.        For these reasons, the contribution of TEs in cfDNA is still
                                                               poorly characterized, but increasing efforts are being devoted to
              Utilizing TE DNA sequences in liquid biopsies offers
            a range of benefits. Cancer cells harbor multiple copies   maximizing the potential of this material. Recently, an alignment-
            of TEs, which inevitably result in a higher concentration   free, genome-wide method was developed for analyzing cfDNA
            of TE DNA released into the blood compared to single-  repeat landscapes, which appeared to be broadly altered in
            copy genes.  The high prevalence of RE DNA within   various human cancers. The authors were able to predict patients
                     68
            cfDNA reduces the requirement for large quantities of   with early-stage cancer and identify the tumor tissue of origin,
            biological fluids and template DNA, making RE DNA and   as the specific RE alterations varied among different tumor
                                                                   74
            its expression products, such as long-interspersed nuclear   types.   Alu elements, the most abundant non-autonomous
            element-1  (LINE-1)  ORF2,  prime  candidate  biomarkers   TEs, are hypomethylated during tumor progression, similar to
            for liquid biopsies in cancer patients.  In particular, TE   LINE-1s. Alu elements also mirror the modified fragmentation
                                           69
            DNA sequences are useful in two key areas: quantifying   patterns observed in the cfDNA of cancer patients, making
            total cfDNA and evaluating cfDNA integrity. 70,71  them valuable for developing techniques aimed at early cancer
                                                               detection using cfDNA. By integrating  LINE-1 methylation,
              Massive global hypomethylation of TEs has been   Alu-derived cfDNA concentrations, and  Alu index, Park  et
            documented in physiological conditions such as aging,   al.  were able to distinguish cancer patients from healthy
                                                                75
            and pathological conditions, such as cancer, resulting   individuals. In addition, Douville et  al.  developed a classifier
                                                                                            76
            in retroelement reactivation and subsequent genomic   whose most important feature was the underrepresentation of
            instability,  which  is  associated  with  poor  prognosis.    the AluS subfamily in cfDNA from patients with solid cancers
                                                         72
            Although this phenomenon has been documented in only   compared to controls.
            a few cancer types, it appears that each tumor displays a
            distinct methylation pattern, reflected in the autonomous   cfRNA sequencing data derived from TEs and other
            LINE-1 methylation profile detectable in cfDNA.    repeat elements is another promising, yet underexplored,
            Methylation is one of the strategies employed by our bodies   application in the  realm of  liquid biopsy.  In a recent
                                                                                   77
            to silence potentially propagating, active, and autonomous   study, Reggiardo  et al.  presented a novel technique
            LINE-1 elements. Indeed, extensive research has focused   that allows for the in-depth characterization of disease-
            on the methylation levels of these retrotransposons as   specific, repeat-derived cfRNAs. Leveraging a highly
            potential epigenetic markers for cancer.  The ability to   sensitive RNA-seq protocol coupled with single-molecule
                                             73
            detect LINE-1 tumor-specific hypomethylation patterns in   nanopore sequencing, the authors were able to detect
            cfDNA could establish LINE-1 as a valuable biomarker for   both coding and non-coding RNAs and provide accurate
            tumor screening and tissue-of-origin identification. While   characterization of protein-coding RNA, long non-coding
            these  pioneering works have  shown promising results,   RNA, LINE, short interspersed nuclear element (SINE),
            further efforts are needed to address the critical limitations   and LTR-derived cfRNAs characterization. The technique
            related to LINE-1 hypomethylation in cfDNA to determine   allows the classification of cancer patients, revealing the
            its  applicability as  a biomarker in  clinical  practice.  The   value and utility of broadly characterizing the so-called
            activity of the few “hot” LINE-1 elements varies depending   “junk” fraction of the genome.
            on the individual tumor type, stage, and the timeframe in
            the clonal evolution of the tumor. Additional studies on   5. Transcriptomics
            patients with different tumor types and stages, as well as   Transcriptome analysis of CTCs has been performed for
            asymptomatic  patients  and  cancer-free  controls,  should   several cancer types, 78-80  both at the bulk and single-cell
            be conducted to evaluate intratumoral and intertumoral   levels, showing that CTCs are a heterogeneous population
            heterogeneity.                                     between and within patients. This technology has greatly
              Despite continuous technological advancements,   contributed to discovering signal pathways involved in
            comprehensively capturing the entire range of TE-mediated   metastasis, resistance to chemotherapy, and epithelial-to-
            structural variants with  high sensitivity and  specificity   mesenchymal transition (EMT).


            Volume 3 Issue 3 (2024)                         5                               doi: 10.36922/gtm.3063
   23   24   25   26   27   28   29   30   31   32   33